Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Who will the reviewers be? Will there be a drug abuse emphasis?

April 26, 2017abuse drug emphasis reviewers

0

Posted

Who will the reviewers be? Will there be a drug abuse emphasis?

1 Answer

0

Posted

The NIH scientific review process is an independent one. As such, the review is administered by NIH staff, but the reviewers themselves are not NIH staff. The Scientific Review Administrator (SRA, who is an NIH employee) will recruit a review committee of scientists specifically for the purpose of reviewing applications to RFA RM-07-004. This is called a Special Emphasis Panel (SEP) and consists of independent reviewers with scientific expertise that is needed, given the content of the applications submitted to this RFA. The review process will be managed by the Office of Extramural Affairs of the National Institute on Drug Abuse (NIDA), but applications need not incorporate drug abuse aims as this RFA is an NIH-wide Roadmap activity. The expertise of the review committee that is convened will be appropriate for the applications received.